SC CTSI Executive Director Susan Autry Trains Academic Leaders In China
Bringing the SC CTSI’s experience in clinical and translational research to the global stage.
Susan Autry, MBA, SC CTSI executive director, joined a distinguished roster of academic leaders from Shanghai Jiao Tong University and the Chinese Academy of Medical Sciences in Shanghai, China, to conduct a series of training workshops on how to build clinical and translational research institutes (CTSIs) and centers.
The three-day workshop, held March 23-25, explained the history and concepts of clinical and translational research at academic health centers in the U.S. and other countries; taught effective ways to build leadership teams at CTSIs; and taught how to develop the key components of CTSIs, such as training programs, clinical research support, informatics and collaborations with industry.
Tom Buchanan, MD, director of the SC CTSI, said, “Susan’s visit to China is an exciting first step in bringing the SC CTSI’s experience in clinical and translational research to the global stage. We intend to continue positioning ourselves as both national and global leaders in clinical and translational research.”
Distinguished leaders at the workshop included Barbara Alving, former director of the NIH National Center for Research Resources—the NIH center that developed the Clinical and Translational Science Awards (CTSA) program, which funded the SC CTSI; Michael Conlon, associate director and chief operating officer at University of Florida’s CTSI; Paul Harris, associate professor of biomedical informatics and director of the Office of Research Informatics at Vanderbilt University; and Tesheia Johnson, chief operating officer of the Yale Center for Clinical Investigation.
“Susan’s visit to China is an exciting first step in bringing the SC CTSI’s experience in clinical and translational research to the global stage. We intend to continue positioning ourselves as both national and global leaders in clinical and translational research.” Tom Buchanan, MD, director of SC CTSI
Attendees—executives and administrators from major hospitals and universities working to establish clinical and translational centers in China—included representatives from Shanghai Jiao Tong University School of Medicine, Nanjing Medical University, Chinese University of Hong Kong and the Shanghai Food and Drug Administration.
The SC CTSI is one of 60 premier research institutes in a national consortium that aims to speed the translation of research discoveries into solutions for better health.
Shanghai Pudong Medical Device Trade Association, Division of Medical and Health, Chinese Academy of Engineering, Science and Technology Committee of Shanghai Municipality, Science and Education Department of Shanghai Municipal Health Bureau and GlobalMD.
The SC CTSI is one of 60 premier research institutes in a national consortium that aims to speed the translation of research discoveries into solutions for better health.
Supported by a $56.8 million grant from the NIH, the Institute unites leading Southern California academic, clinical, and community health organizations. Together, they identify major regional health problems and offer researchers the support needed to develop creative solutions for those problems.
